- idUS
- Listar por autor
Listar por autor "Pelayo-Terán, José María"
Mostrando ítems 1-3 de 3
-
Artículo
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
Gómez-Revuelta, Marcos; Pelayo-Terán, José María; Juncal-Ruiz, María; Vázquez-Bourgon, Javier; Suárez-Pinilla, Paula; Romero-Jiménez, Rodrigo; Crespo Facorro, Benedicto (Oxford University Press, 2020)Background: Different effectiveness profiles among antipsychotics may be a key point to optimize treatment in patients ...
-
Artículo
Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial
Garrido Sánchez, Lucía; Gómez-Revuelta, Marcos; Ortiz García de la Foz, Víctor; Pelayo-Terán, José María; Juncal-Ruiz, María; Ruiz Veguilla, Miguel; Mayoral-van Son, Jaqueline; Ayesa-Arriola, Rosa; Vázquez-Bourgon, Javier; Crespo Facorro, Benedicto (Oxford University Press, 2022-07-27)Background Antipsychotic choice for the acute phase of a first episode of psychosis (FEP) is of the utmost importance ...
-
Artículo
Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program
Pardo-de-Santayana, Guillermo; Vázquez-Bourgon, Javier; Gómez-Revuelta, Marcos; Ayesa-Arriola, Rosa; Ortiz García de la Foz, Víctor; Crespo Facorro, Benedicto; Pelayo-Terán, José María (Elsevier, 2020)This article describes data related to the research study entitled "Duration of active psychosis during early phases of ...